TLR3 and colitis: Moreover, poly (I:C) enhances the efficacy of chemotherapy in paclitaxel-resistant colon cancer cells through the TLR3–UNC93B1–IFN-β signaling axis (Zhao et al., 2019) and can significantly prevent the occurrence of DSS-induced colitis (Zhao et al., 2017).